Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

VITAL to Distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan

Published: Monday, October 29, 2012
Last Updated: Monday, October 29, 2012
Bookmark and Share
Imagine Eyes’ retinal camera has recently received Shonin regulatory approval.

Imagine Eyes and VITAL Corporation have announced that VITAL will distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan.

“VITAL has a proud history of identifying novel medical technologies that benefit doctors and patients alike” states Masao Ichinoseki, President of VITAL Corporation.

Ichinoseki continued, “Imagine Eyes’ retinal camera recently received Shonin (NINSHO) approval from the Japanese Ministry of Health, Labor and Welfare and can now enable Japanese ophthalmologists to visualize their patients’ retinas in unparalleled detail. We hope that this will allow them to enhance the quality of care they provide and help them save vision.”

“Japan is the world’s second largest market for medical devices after the Unites States” remarks Tomoki Tateishi, Marketing Director at VITAL Corporation.

Tateishi continued, “Historically, VITAL uses an effective strategy based in part on inviting leading experts in their field to come and present their experience with the cutting-edge medical devices we supply especially in interventional cardiology and cardiovascular surgery. We will use a similar approach as part of marketing the rtx1 Adaptive Optics Retinal Camera in Japan and we expect to see rapid adoption by ophthalmologists across the country. The first such event will be held on October 26, 2012, and will spotlight the work of both French and Japanese researchers that use the rtx1.”

“Several leading Japanese researchers embraced the rtx1’s cellular-level-retinal-imaging abilities very early on, and we are very thankful to them for their support as it has been instrumental in creating demand in their country” says Nicolas Chateau, Imagine Eyes’ Cofounder and CEO.

Chateau continued, “We look forward to working with VITAL to provide Japanese ophthalmologists with a new tool that will help further sight-saving research today and potentially improve the already impressive healthcare citizens receive in the future.”

VITAL provides demonstrations of the rtx1 Adaptive Optics Retinal Camera in room E at the 66th Annual Japanese Clinical Ophthalmology Congress in Kyoto Japan from October 25-28, 2012.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
10X Genomics Releases Linked-Read Data from NIST Genome Samples
Genome in a Bottle Consortium data submission for webinar presentation and public availability.
Study Sheds Light on the Causes of Cerebral Palsy
Wider use of genetic testing in children with CP should be considered.
Pitt Researchers to Monitor Resistance to HIV Drugs in Africa
Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.
Environmental Epigenetics Affects Disease, Evolution
Researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism’s DNA sequence.
Critical New Insights on DNA Repair
The enzyme fumarase is key to reversing genetic damage leading to cancer and therapy resistance.
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Nanoparticles Used to Breach Mucus Barrier in Lungs
Proof-of-concept study conducted in mice is a key step toward better treatments for lung diseases.
New Biosensors for Managing Microbial ‘Workers’
Researchers at Harvard’s Wyss Institute have unveiled new biosensors that enable scientists to more effectively control and 'communicate with' engineered bacteria.
Researchers Identify Protein in Mice that Helps Prepare for Healthy Egg-sperm Union
Protein RGS2 plays a critical role in preserving the fertilizability of the ovulated egg.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!